Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Pediatric Open-Label Extension Study
A 104-Week, Flexible-Dose, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Effectiveness of Lurasidone in Pediatric Subjects
Status: Enrolling
Updated:  12/31/1969
Jersey Shore University Medical Center
mi
from
Neptune, NJ
Pediatric Open-Label Extension Study
A 104-Week, Flexible-Dose, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Effectiveness of Lurasidone in Pediatric Subjects
Status: Enrolling
Updated: 12/31/1969
Jersey Shore University Medical Center
mi
from
Neptune, NJ
Click here to add this to my saved trials
Mind-Body Rehabilitative Program for Veterans With mTBI (Mild Traumatic Brain Injury)
Evaluating a Novel Sleep-focused Mind-body Rehabilitative Program for Veterans With mTBI and Other "Polytrauma" Symptoms: An Randomized Controlled Trial (RCT) Study
Status: Enrolling
Updated:  12/31/1969
Pain Research Center
mi
from
Salt Lake City, UT
Mind-Body Rehabilitative Program for Veterans With mTBI (Mild Traumatic Brain Injury)
Evaluating a Novel Sleep-focused Mind-body Rehabilitative Program for Veterans With mTBI and Other "Polytrauma" Symptoms: An Randomized Controlled Trial (RCT) Study
Status: Enrolling
Updated: 12/31/1969
Pain Research Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Mind-Body Rehabilitative Program for Veterans With mTBI (Mild Traumatic Brain Injury)
Evaluating a Novel Sleep-focused Mind-body Rehabilitative Program for Veterans With mTBI and Other "Polytrauma" Symptoms: An Randomized Controlled Trial (RCT) Study
Status: Enrolling
Updated:  12/31/1969
VA Salt Lake City Heath Care System
mi
from
Salt Lake City, UT
Mind-Body Rehabilitative Program for Veterans With mTBI (Mild Traumatic Brain Injury)
Evaluating a Novel Sleep-focused Mind-body Rehabilitative Program for Veterans With mTBI and Other "Polytrauma" Symptoms: An Randomized Controlled Trial (RCT) Study
Status: Enrolling
Updated: 12/31/1969
VA Salt Lake City Heath Care System
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Strategies for Recovery of Dexterity Post Stroke
Strategies for Recovery of Dexterity Post Stroke
Status: Enrolling
Updated:  12/31/1969
New York University School of Medicine
mi
from
New York, NY
Strategies for Recovery of Dexterity Post Stroke
Strategies for Recovery of Dexterity Post Stroke
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
Status: Enrolling
Updated:  12/31/1969
Site US00009
mi
from
Anchorage, AK
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
Status: Enrolling
Updated: 12/31/1969
Site US00009
mi
from
Anchorage, AK
Click here to add this to my saved trials
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
Status: Enrolling
Updated:  12/31/1969
Site US00001
mi
from
Detroit, MI
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
Status: Enrolling
Updated: 12/31/1969
Site US00001
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
Status: Enrolling
Updated:  12/31/1969
Site US10047
mi
from
New York, NY
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
Status: Enrolling
Updated: 12/31/1969
Site US10047
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
Status: Enrolling
Updated:  12/31/1969
Site US10046
mi
from
Syracuse, NY
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
Status: Enrolling
Updated: 12/31/1969
Site US10046
mi
from
Syracuse, NY
Click here to add this to my saved trials
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
Status: Enrolling
Updated:  12/31/1969
Site US10016
mi
from
Durham, NC
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
Status: Enrolling
Updated: 12/31/1969
Site US10016
mi
from
Durham, NC
Click here to add this to my saved trials
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
Status: Enrolling
Updated:  12/31/1969
Site US10002
mi
from
Dallas, TX
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
Status: Enrolling
Updated: 12/31/1969
Site US10002
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
Status: Enrolling
Updated:  12/31/1969
Site: US10533
mi
from
Seattle, WA
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
Status: Enrolling
Updated: 12/31/1969
Site: US10533
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
Status: Enrolling
Updated:  12/31/1969
Site AR54001
mi
from
Berazategui,
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
Status: Enrolling
Updated: 12/31/1969
Site AR54001
mi
from
Berazategui,
Click here to add this to my saved trials
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
Status: Enrolling
Updated:  12/31/1969
Site US10026
mi
from
Bronx, NY
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
Status: Enrolling
Updated: 12/31/1969
Site US10026
mi
from
Bronx, NY
Click here to add this to my saved trials
Oral Immunotherapy for Wheat Allergy
Oral Immunotherapy for Wheat Allergy
Status: Enrolling
Updated:  12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
Oral Immunotherapy for Wheat Allergy
Oral Immunotherapy for Wheat Allergy
Status: Enrolling
Updated: 12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Oral Immunotherapy for Wheat Allergy
Oral Immunotherapy for Wheat Allergy
Status: Enrolling
Updated:  12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Oral Immunotherapy for Wheat Allergy
Oral Immunotherapy for Wheat Allergy
Status: Enrolling
Updated: 12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Oral Immunotherapy for Wheat Allergy
Oral Immunotherapy for Wheat Allergy
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Oral Immunotherapy for Wheat Allergy
Oral Immunotherapy for Wheat Allergy
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oral Immunotherapy for Wheat Allergy
Oral Immunotherapy for Wheat Allergy
Status: Enrolling
Updated:  12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Oral Immunotherapy for Wheat Allergy
Oral Immunotherapy for Wheat Allergy
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of California Davis
mi
from
Davis, CA
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of California Davis
mi
from
Davis, CA
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Colorado at Denver
mi
from
Denver, CO
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Colorado at Denver
mi
from
Denver, CO
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Miami Miller School of Medicine
mi
from
Miami, FL
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Evanston, IL
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Evanston, IL
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University at Buffalo - State University of New York
mi
from
Buffalo, NY
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University at Buffalo - State University of New York
mi
from
Buffalo, NY
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Rochester
mi
from
Rochester, NY
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University at Stony Brook, The State University of New York
mi
from
Stony Brook, NY
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University at Stony Brook, The State University of New York
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University at Upstate, The State University of New York
mi
from
Syracuse, NY
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University at Upstate, The State University of New York
mi
from
Syracuse, NY
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati Department of Neurology
mi
from
Cincinnati, OH
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati Department of Neurology
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Virginia, Charlottesville
mi
from
Charlottesville, VA
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Virginia, Charlottesville
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center-Seattle
mi
from
Seattle, WA
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center-Seattle
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine St. Louis
mi
from
Saint Louis, MO
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Cornell Medical College
mi
from
New York, NY
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated:  12/31/1969
UI Health Care-River Crossing
mi
from
Riverside, IA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated: 12/31/1969
UI Health Care-River Crossing
mi
from
Riverside, IA
Click here to add this to my saved trials
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated:  12/31/1969
Akron Mercy Medical Clinic
mi
from
Akron, IA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated: 12/31/1969
Akron Mercy Medical Clinic
mi
from
Akron, IA
Click here to add this to my saved trials
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated:  12/31/1969
Iowa Specialty Hospitals - Belmond Clinic
mi
from
Belmond, IA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated: 12/31/1969
Iowa Specialty Hospitals - Belmond Clinic
mi
from
Belmond, IA
Click here to add this to my saved trials
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated:  12/31/1969
Employee Health Clinic, Mercy Cedar Rapids
mi
from
Cedar Rapids, IA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated: 12/31/1969
Employee Health Clinic, Mercy Cedar Rapids
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated:  12/31/1969
Iowa Speciality Hospitals - Clarion Clinic
mi
from
Clarion, IA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated: 12/31/1969
Iowa Speciality Hospitals - Clarion Clinic
mi
from
Clarion, IA
Click here to add this to my saved trials